• "It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein
• A broad wastewater screening and clinical data surveillance for virus-related diseases in the metropolitan Detroit area in Michigan
• A case of human T-lymphotropic virus-1-associated lichenoid dermatitis
• A promising advance in blocking HTLV-1 transmission: Addressing a global public health problem
• Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer
• Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report
• Altered apoptosis and proliferation in milk cells and PBMc from BLV-infected bovines with different proviral loads: Possible role of the BCL-2 family proteins, TNF-alpha, and receptors
• An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits
• Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
• Association between Brain White Matter Lesions and Disease Activity in HAM/TSP Patients
• Bovine Leukemia Virus molecular detection and associated factors among dairy herd workers in Antioquia, Colombia
• Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment
• Case Report: Disseminated Paracoccidioidomycosis and Strongyloides Hyperinfection in a Patient with Human T-Lymphotropic Virus Type 1/2 Infection
• Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention
• Characterization and application of recombinant Bovine Leukemia Virus Env protein
• Clinical Features and Survival Outcome in Aggressive-Type Adult T-Cell Leukemia/Lymphoma Patients: Real-Life Experience of a Single Center from an HTLV-1 Endemic Country
• Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers
• Cytokine secretion in stem cells of cattle infected with bovine leukaemia virus
• Determination of molecular epidemiologic pattern of human T-lymphotropic virus type 1 (HTLV-1) in Alborz province, Iran
• Development of Dry and Liquid Duplex Reagent Mix-Based Polymerase Chain Reaction Assays as Novel Tools for the Rapid and Easy Quantification of Bovine Leukemia Virus (BLV) Proviral Loads
• Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma
• Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
• Durable remission with lenalidomide in a patient with early relapse of adult T-cell leukemia/lymphoma after cord blood transplantation
• Effectiveness assessment of a home-based exercise intervention in mitigating HTLV-1 associated disabilities: A validation study
• Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals
• Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus
• Evaluating a Retro-Inverso Type Inhibitor of HTLV-1 Protease as a Competitive Inhibitor
• Evaluating tocilizumab safety and immunomodulatory effects under ocular HTLV-1 infection in vitro
• Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicator for prognosis of aggressive ATL
• Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL
• Gene expression profiling of p53 and c-myc in HTLV-1 positive blood donors in Congo
• Gene-to-gene coordinated regulation of transcription and alternative splicing by 3D chromatin remodeling upon NF-κB activation
• Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan
• High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia
• High Ratio of Human T Cell Lymphotropic Virus Transmission and Prevalence of Human T Cell Lymphotropic Virus Type 1-Associated Diseases in Brazilian Family Groups Followed Up by the GIPH Cohort
• Highly homologous simian T-cell leukemia virus type 1 genome in Japanese macaques: a large cohort study
• HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load
• How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis
• HTLV in Sweden
• HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations
• HTLV-1 in Brazil: epidemiological scenario in the highest endemic country in the world
• HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1-associated myelopathy
• HTLV-1 infected T cells cause bone loss via small extracellular vesicles
• HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
• HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation
• HTLV-1/2 infection in Italy: a narrative review of epidemiological studies
• Human T-cell leukemia virus type 1 uses a specific tRNA(Pro) isodecoder to prime reverse transcription
• Human T-lymphotropic virus 1/2 infection among prisoners of a major penitentiary complex of Goias State, Central-West Brazil
• Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
• IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1
• Imbalanced IL10/TGF-beta production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis
• IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells <em>via</em> cereblon through downregulation of target proteins and their downstream effectors
• Impact and economic analysis of human T-cell lymphotropic virus type 1 (HTLV-1)-targeted antenatal screening, England and Wales, 2021
• Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
• Infection with bovine leukemia virus belonging to group A or B-1 contributes more strongly to the development of enzootic bovine leukosis in young cattle than the presence of bovine lymphocyte antigen-DRB3 susceptibility alleles
• Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease
• Inflammatory progressive multifocal leukoencephalopathy with human T-cell lymphotropic virus-1 coinfection
• Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via modulation of NF-kappaB, AP-1, and Akt signaling
• Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study
• Low seroprevalence of anti-human T-cell leukemia virus-I/II antibodies among brain-dead donors in Tuscany-An 8-year observational study
• Making HTLV-1 and those affected visible
• MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV
• Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study
• Molecular analysis of the env, LTR, and pX regions of bovine leukemia virus in dairy cattle of Türkiye
• Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
• Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report
• NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice
• Non-cancerous complications in HTLV-1 carriers
• Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis
• Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity
• PCBP1 interacts with the HTLV-1 Tax oncoprotein to potentiate NF-kappaB activation
• Performance of immunological assays for universal and differential diagnosis of HTLV-1/2 infection in candidates for blood donations from the Brazilian Amazon
• Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands Study
• Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia
• Prevalence of HTLV-1 and Hepatitis B Surface Antigen (HBsAg) Positivity among MSM Attending a Large HIV Treatment Centre in Trinidad
• Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta-analysis
• Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance
• Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques
• Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins
• Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions
• Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells
• Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis
• Role of Interleukin-17 cytokine family in human T-cell lymphotropic virus type 1 (HTLV-1) infection and associated diseases
• Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis
• Screening for HTLV-1 infection should be expanded in Europe
• Seroprevalence of reproductive and infectious diseases in cattle: the case of Madre de Dios in the Peruvian southeastern tropics
• Southern African Origin of HTLV-1 in Romania
• Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1
• Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review
• Temporal patterns of bovine leukemia virus infection in dairy herds in Atlantic Canada
• The history of the Japanese Society for Neuro-infectious Diseases: Foundation, objectives, and legacy
• The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7
• The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer
• The impact of HTLV-1 expression on the 3D structure and expression of host chromatin
• The importance of confirmatory assays in testing blood donors for human T-cell lymphotropic virus
• The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein
• Trans-Activation of the Coactivator-Associated Arginine Methyltransferase 1 (Carm1) Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1
• Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome
• Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses
• Why not eliminate HTLV-1 while eliminating HIV-1?